A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC

Summary

This study is a phase II, open label, single-arm and exploratory clinical trial. The purpose of this study is to observe the efficacy and safety of consolidation immunotherapy with Toripalimab following postoperative radiotherapy or chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinomas (HNSCC).

Timeline

Start

2021-06-22

Primary completion

2024-12-01

Completion

2027-05-01

Drugs

Indications